NCT04019704.
Methods | Randomised, double‐blind, placebo‐controlled study |
Participants | 327 participants with depression |
Interventions | Drug: AXS‐05 Drug: placebo |
Outcomes | Adverse events MADRS |
Notes | Trial completed December 2019, no results available yet. |